{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:49:50Z","timestamp":1794923390800,"version":"4.9.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer Netherlands","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH 201211047RSC"],"award-info":[{"award-number":["NTUH 201211047RSC"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ijantimicag.2025.107669","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:05:54Z","timestamp":1763636754000},"page":"107669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Ceftazidime-avibactam resistance among clinical isolates of Citrobacter freundii, Morganella morganii, Providencia spp. and Serratia marcescens across five continents: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016\u20132023"],"prefix":"10.1016","volume":"67","author":[{"given":"Hao-En","family":"Jan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9465-8692","authenticated-orcid":false,"given":"Jiun-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Yao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Chung","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7805-4178","authenticated-orcid":false,"given":"Yu-Tsung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7502-9225","authenticated-orcid":false,"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2025.107669_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.015","article-title":"Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third-generation cephalosporins? A narrative review","volume":"55","author":"Mizrahi","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0002","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3390\/antibiotics13050455","article-title":"Genomic characterization of carbapenemase-producing Enterobacter hormaechei, Serratia marcescens, Citrobacter freundii, Providencia stuartii, and Morganella morganii clinical isolates from Bulgaria","volume":"130","author":"Sabtcheva","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0003","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","article-title":"Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli","volume":"56","author":"Zeng","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0004","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"79","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s15010-023-02108-6","article-title":"Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis","volume":"52","author":"Chen","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0006","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant gram-negative bacilli (endorsed by European society of intensive care medicine)","volume":"28","author":"Paul","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0007","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jmii.2022.09.010","article-title":"Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients","volume":"56","author":"Liu","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0008","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jgar.2025.01.011","article-title":"Genetic basis of carbapenem-resistant clinical Serratia marcescens in Japan","volume":"42","author":"Khalifa","year":"2025","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04144-22","article-title":"Molecular epidemiology of global carbapenemase-producing Citrobacter spp. (2015-2017)","volume":"11","author":"Nobrega","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10123-024-00523-9","article-title":"Epidemiological and molecular study of Providencia rettgeri outbreak at a university hospital during the COVID-19 reference center","volume":"28","author":"Da Silva Pimenta","year":"2025","journal-title":"Int Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0011","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.47.2400587","article-title":"Genomic surveillance detects interregional spread of New Delhi metallo-beta-lactamase-1-producing Providencia stuartii in hospitals, Romania, December 2021 to September 2023","volume":"29","author":"Linkevicius","year":"2024","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0012","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jmii.2024.04.004","article-title":"Epidemiology and antimicrobial susceptibility profiles of enterobacterales causing bloodstream infections before and during COVID-19 pandemic: results of the study for monitoring Antimicrobial Resistance trends (SMART) in Taiwan, 2018-2021","volume":"57","author":"Lee","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0013","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jmii.2022.09.009","article-title":"In vitro susceptibility of common enterobacterales to eravacycline in Taiwan","volume":"56","author":"Huang","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107105","article-title":"High ceftazidime-avibactam resistance among carbapenem-resistant Enterobacter species: data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-2021","volume":"63","author":"Wang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0015","unstructured":"Pfizer. ATLAS (Antimicrobial Testing Leadership and Surveillance). https:\/\/atlas-surveillance.com. accessed on May 20, 2025."},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107103","article-title":"Global trends in nonsusceptibility rates of Escherichia coli isolates to meropenem and ceftazidime\/avibactam: data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2014-21","volume":"63","author":"Wang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0017","unstructured":"Performance standards for antimicrobial susceptibility testing. 35th ed. Pennsylvania: CLSI;2025. CLSI supplement M100."},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0018","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, version 15.0, 2025. http:\/\/www.eucast.org\/clinical_breakpoints\/.accessed on May 20, 2025"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0019","unstructured":"Pfizer. ATLAS (Antimicrobial Testing Leadership and Surveillance): definitions. https:\/\/atlas-surveillance.com\/resources\/definitions [Accessed October 4, 2025]."},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12879-024-09107-4","article-title":"The importance of meropenem resistance, rather than imipenem resistance, in defining carbapenem-resistant Enterobacterales for public health surveillance: an analysis of national population-based surveillance","volume":"24","author":"Ikenoue","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0021","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1093\/jac\/dkad127","article-title":"Incidence of ESBLs and carbapenemases among enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019","volume":"78","author":"Gales","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0022","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1128\/AAC.05186-14","article-title":"Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013","volume":"59","author":"Lob","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0023","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00472-17","article-title":"In vitro activity of aztreonam-avibactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated by clinical laboratories in 40 countries from 2012 to 2015","volume":"61","author":"Karlowsky","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0024","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/phar.4629","article-title":"Aztreonam-avibactam: the dynamic duo against multidrug-resistant gram-negative pathogens","volume":"44","author":"Al Musawa","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12866-023-03032-3","article-title":"Analysis of resistance genes of carbapenem-resistant Providencia rettgeri using whole genome sequencing","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2024.116246","article-title":"Identification of Providencia spp. Clinical isolates co-producing carbapenemases IMP-27, OXA-24, and OXA-58 in Mexico","volume":"109","author":"Bocanegra-Ibarias","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1074612","article-title":"Coexistence of bla(IMP-4), bla(NDM-1) and bla(OXA-1) in bla(KPC-2)-producing Citrobacter freundii of clinical origin in China","volume":"14","author":"Qiao","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0028","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fcimb.2020.00314","article-title":"Dissemination of carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China","volume":"10","author":"Han","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.744431","article-title":"Carbapenem-resistant Citrobacter spp. As an emerging concern in the hospital-setting: results from a genome-based regional surveillance study","volume":"11","author":"Yao","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00234-25","article-title":"Infections caused by clonal spread of metallo-beta-lactamase-producing Enterobacter cloacae complex isolates at a southern Taiwan hospital","author":"Cia","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0031","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10096-012-1748-x","article-title":"Bloodstream infections caused by IMP-8-producing Enterobacteriaceae isolates: the need for clinical laboratory detection of metallo-\u03b2-lactamases?","volume":"32","author":"Yan","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0032","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jmii.2024.05.013","article-title":"Comparison of ERIC carbapenem-resistant Enterobacteriaceae test, BD Phoenix CPO detect panel, and NG-test CARBA 5 for the detection of main carbapenemase types of carbapenem-resistant enterobacterales","volume":"57","author":"Lin","year":"2024","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0033","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3201\/eid2611.202203","article-title":"KPC-3-producing Serratia marcescens outbreak between acute and long-term care facilities, Florida, USA","volume":"26","author":"Jimenez","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0034","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AAC.38.1.71","article-title":"Molecular characterization of an enterobacterial metallo-beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance","volume":"38","author":"Osano","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0035","article-title":"First report of bla (IMP-4) and bla(SRT-2) coproducing Serratia marcescens clinical isolate in China","volume":"12","author":"Huang","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0036","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1099\/jmm.0.006874-0","article-title":"Identification of plasmid- and integron-borne blaIMP-1 and blaIMP-10 in clinical isolates of Serratia marcescens","volume":"58","author":"Hu","year":"2009","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2025.107669_bib0037","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1128\/AAC.39.4.824","article-title":"Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens","volume":"39","author":"Ito","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ijantimicag.2025.107669_bib0038","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00651-22","article-title":"Molecular mechanisms of resistance to ceftazidime\/avibactam in clinical isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American hospitals","volume":"8","author":"Mojica","year":"2023","journal-title":"mSphere"},{"issue":"3","key":"10.1016\/j.ijantimicag.2025.107669_bib0039","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/AAC.02429-13","article-title":"Antimicrobial activity of ceftazidime\u2013avibactam against gram-negative organisms collected from U.S. medical centers in 2012","volume":"58","author":"Sader","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2025.107669_bib0040","doi-asserted-by":"crossref","first-page":"e547","DOI":"10.1016\/S2666-5247(23)00407-X","article-title":"Spread of carbapenemase-producing Morganella spp. From 2013 to 2021: a comparative genomic study","volume":"5","author":"Bonnin","year":"2024","journal-title":"The Lancet Microbe"},{"issue":"4","key":"10.1016\/j.ijantimicag.2025.107669_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02476-24","article-title":"Carbapenem-resistant Morganella morganii carrying blaKPC-2 or blaNDM-1 in the clinic: one-decade genomic epidemiology analysis","volume":"13","author":"Yao","year":"2025","journal-title":"Microbiol Spectr"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925002249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857925002249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:33:46Z","timestamp":1773866026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857925002249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0924857925002249"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107669","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime-avibactam resistance among clinical isolates of Citrobacter freundii, Morganella morganii, Providencia spp. and Serratia marcescens across five continents: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme, 2016\u20132023","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2025.107669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107669"}}